Protein overexpression of p53 was a significant prognostic marker of shortened survival as well as a predictive marker to indicate greater survival benefits of adjuvant chemotherapy in completely resected NSCLC patients [226]. Here, TP53 is linked to non-small cell lung carcinoma.